Cite
Impact of positive ZEB1 expression in patients with epithelial ovarian carcinoma as an oncologic outcome-predicting indicator
MLA
Shiro Suzuki, et al. “Impact of Positive ZEB1 Expression in Patients with Epithelial Ovarian Carcinoma as an Oncologic Outcome-Predicting Indicator.” Oncology Letters, vol. 14, no. 4, Nov. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bcf941a6ba62c362ba8c8ae6bee8d304&authtype=sso&custid=ns315887.
APA
Shiro Suzuki, Kiyosumi Shibata, Kaoru Niimi, Jun Sakata, Hiroaki Kajiyama, Ryuichiro Sekiya, Fumitaka Kikkawa, Fumi Utsumi, & Takeshi Senga. (2016). Impact of positive ZEB1 expression in patients with epithelial ovarian carcinoma as an oncologic outcome-predicting indicator. Oncology Letters, 14(4).
Chicago
Shiro Suzuki, Kiyosumi Shibata, Kaoru Niimi, Jun Sakata, Hiroaki Kajiyama, Ryuichiro Sekiya, Fumitaka Kikkawa, Fumi Utsumi, and Takeshi Senga. 2016. “Impact of Positive ZEB1 Expression in Patients with Epithelial Ovarian Carcinoma as an Oncologic Outcome-Predicting Indicator.” Oncology Letters 14 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bcf941a6ba62c362ba8c8ae6bee8d304&authtype=sso&custid=ns315887.